Mario Alberto Accardi's most recent trade in Centessa Pharmaceuticals plc - ADR was a trade of 597 Ordinary Shares done at an average price of $17.2 . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals p... | Mario Alberto Accardi | President, Orexin Program | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.17 per share. | 01 Aug 2025 | 597 | 207,566 | - | 17.2 | 10,250 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 15.23 per share. | 29 Jul 2025 | 8,322 | 208,163 | - | 15.2 | 126,751 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 15,000 | 15,300 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 24 Jun 2025 | 15,000 | 216,485 | - | 14 | 210,000 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 24 Jun 2025 | 15,000 | 231,485 | - | 3.9 | 57,750 | Ordinary Shares |